HeartSciences Inc
HSCS2.580USD
-0.060-2.27%
收盘 12/24, 13:00（美东）报价延迟15分钟
7.92M总市值
亏损市盈率 TTM
关于 HeartSciences Inc 公司
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
HeartSciences Inc简介
公司代码HSCS
公司名称HeartSciences Inc
上市日期Jun 15, 2022
CEOSimpson (Andrew)
员工数量15
证券类型Ordinary Share
年结日Jun 15
公司地址550 Reserve St, Suite 360
城市SOUTHLAKE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编76092
电话16822377781
网址https://heartsciences.com/
公司代码HSCS
上市日期Jun 15, 2022
CEOSimpson (Andrew)
HeartSciences Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.38K
+1597.44%
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-99.08%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.38K
+1597.44%
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-99.08%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
DRW Securities, LLC
2.63%
Simpson (Andrew)
2.34%
Icahn School of Medicine at Mount Sinai
1.53%
Matthews (John H)
1.25%
TFB Advisors LLC
0.94%
其他
91.32%
持股股东
持股股东
占比
DRW Securities, LLC
2.63%
Simpson (Andrew)
2.34%
Icahn School of Medicine at Mount Sinai
1.53%
Matthews (John H)
1.25%
TFB Advisors LLC
0.94%
其他
91.32%
股东类型
持股股东
占比
Investment Advisor
5.08%
Individual Investor
3.68%
Corporation
1.53%
Investment Advisor/Hedge Fund
0.40%
Research Firm
0.02%
其他
89.29%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
33
108.58K
3.54%
+49.69K
2025Q2
39
134.20K
6.56%
-24.66K
2025Q1
40
132.05K
12.22%
-6.21K
2024Q4
39
108.59K
11.08%
-22.21K
2024Q3
39
110.23K
11.34%
-17.15K
2024Q2
40
110.31K
22.15%
+69.79K
2024Q1
41
120.50K
23.97%
+81.89K
2023Q4
35
116.99K
23.49%
+83.22K
2023Q3
27
29.10K
27.79%
-2.40K
2023Q2
25
31.29K
32.13%
+2.11K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Simpson (Andrew)
4.38K
0.14%
--
--
Jul 23, 2025
Icahn School of Medicine at Mount Sinai
48.55K
1.58%
--
--
Sep 24, 2024
Matthews (John H)
39.73K
1.29%
--
--
Sep 24, 2024
Astoria Strategic Wealth, Inc.
18.93K
0.62%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
1.32K
0.04%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
11.60K
0.38%
+2.19K
+23.21%
Jun 30, 2025
Advisory Services Network, LLC
10.00K
0.33%
+10.00K
--
Jun 30, 2025
Desjardins Securities Inc.
400.00
0.01%
+400.00
--
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
公告日期
类型
比率
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
常见问题
HeartSciences Inc的前五大股东是谁？
HeartSciences Inc 的前五大股东如下：
Simpson (Andrew)持有股份：4.38K，占总股份比例：0.14%。
Icahn School of Medicine at Mount Sinai持有股份：48.55K，占总股份比例：1.58%。
Matthews (John H)持有股份：39.73K，占总股份比例：1.29%。
Astoria Strategic Wealth, Inc.持有股份：18.93K，占总股份比例：0.62%。
The Vanguard Group, Inc.持有股份：1.32K，占总股份比例：0.04%。
Simpson (Andrew)持有股份：4.38K，占总股份比例：0.14%。
Icahn School of Medicine at Mount Sinai持有股份：48.55K，占总股份比例：1.58%。
Matthews (John H)持有股份：39.73K，占总股份比例：1.29%。
Astoria Strategic Wealth, Inc.持有股份：18.93K，占总股份比例：0.62%。
The Vanguard Group, Inc.持有股份：1.32K，占总股份比例：0.04%。
HeartSciences Inc的前三大股东类型是什么？
HeartSciences Inc 的前三大股东类型分别是：
DRW Securities, LLC
Simpson (Andrew)
Icahn School of Medicine at Mount Sinai
DRW Securities, LLC
Simpson (Andrew)
Icahn School of Medicine at Mount Sinai
有多少机构持有HeartSciences Inc(HSCS)的股份？
截至2025Q3，共有33家机构持有HeartSciences Inc的股份，合计持有的股份价值约为108.58K，占公司总股份的3.54%。与2025Q2相比，机构持股有所增加，增幅为-3.02%。
哪个业务部门对HeartSciences Inc的收入贡献最大？
在--，--业务部门对HeartSciences Inc的收入贡献最大，创收--，占总收入的--%。
